Dr. Robert Grant developed a treatment — a daily pill known as pre-exposure prophylaxis, or PrEP — that could stop the AIDS crisis. We look at why that hasn’t happened. Guests: Dr. Grant, who has been working on H.I.V. treatment and prevention for over 30 years, and Donald G. McNeil Jr., a science and health reporter for The New York Times. For more information on today’s episode, visit nytimes.com/thedaily. Background reading: Gilead Sciences, the maker of Truvada, the only drug approved to prevent H.I.V. infection, will donate enough of the drug to supply 200,000 patients, but critics questioned the company’s motives.The high cost of drugs remains a major obstacle to ending the AIDS epidemic.Here’s more information about PrEP from the Centers for Disease Control and Prevention website.
Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher. For more podcasts and narrated articles, download The New York Times app at nytimes.com/app. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Nachrichten
The Daily Folgen
This is what the news should sound like. The biggest stories of our time, told by the best journalists in the world. Hosted by Michael Barbaro, Rachel Abrams and Natalie Kitroeff. Twenty minutes a day, six days a week, ready by 6 a.m. Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher.
Folgen von The Daily
2951 Folgen
-
Folge vom 05.06.2019This Drug Could End H.I.V. Why Hasn’t It?
-
Folge vom 04.06.2019How a Secret U.S. Cyberweapon BackfiredA criminal group has held computer systems for the city of Baltimore hostage for nearly a month — paralyzing everything from email to the real estate market to the payment of water bills. But what residents don’t know is that a major component of the malware used to shut down the system was developed nearby by a federal government agency. Guest: Scott Shane, who covers national security and the U.S. intelligence community for The New York Times. For more information on today’s episode, visit nytimes.com/thedaily. Background reading:People involved in the investigation say the N.S.A. tool, EternalBlue, was found in Baltimore’s network by four contractors hired to restore computer services. The N.S.A. says that’s not the case. Cybercriminals have been targeting other vulnerable American towns and cities, from Pennsylvania to Texas, in ways that could disrupt local governments for months. Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher. For more podcasts and narrated articles, download The New York Times app at nytimes.com/app. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
-
Folge vom 03.06.2019The Legacy of Rachel Held EvansIn a brief but prolific career, a young writer asked whether evangelical Christianity could change. In doing so, she changed it. Guests: Elizabeth Dias, who covers religion for The Times, in conversation with Natalie Kitroeff. For more information on today’s episode, visit nytimes.com/thedaily. Background reading: Read the Times obituary for Rachel Held Evans, the best-selling author who challenged conservative Christianity and gave voice to a generation of wandering evangelicals wrestling with their faith. Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher. For more podcasts and narrated articles, download The New York Times app at nytimes.com/app. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
-
Folge vom 31.05.2019Death, Profit and Disclosure at a Children’s HospitalA Times investigation found that doctors at UNC Children’s Hospital suspected that children with complex heart conditions had been dying at higher-than-expected rates, and even children with low-risk conditions seemed to do poorly. Secret recordings shared with our colleague reveal what was happening inside the hospital. Guest: Ellen Gabler, an investigative reporter for The New York Times. For more information on today’s episode, visit nytimes.com/thedaily. Background reading:Limited information released by UNC shows that the hospital’s cardiac surgery mortality rate from July 2013 through June 2017 was higher than those of most of the 82 hospitals that publicly report similar information.Listen to the audio recordings that provide an unfiltered look behind closed doors at the hospital. Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify. You can also subscribe via your favorite podcast app here https://www.nytimes.com/activate-access/audio?source=podcatcher. For more podcasts and narrated articles, download The New York Times app at nytimes.com/app. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.